Gineco.com.br

O que é
Sintomas
Causa dos sintomas
Porque tratar
Qualidade de vida
Tratamentos
Tratamento Hormonal

Terapias Alternativas

Leia mais
Mail and F.A.Q.
Faça sua pergunta

Qualidade de Vida da Mulher

Há comprovação científica que o tratamento hormonal em mulheres sintomáticas no início da menopausa tem os seguintes benefícios:

  1. Evita a osteoporose;

  2. Melhora os fogachos;

  3. Melhora a vida sexual;

  4. Protege contra o câncer de colon;

  5. Melhora a qualidade de vida da mulher;

  6. Estudos epidemiológicos sugerem que pode haver prevenção da demência senil (Alzheimer) em mulheres no entanto estudos estatísticos não conseguiram provar esta afirmação.

Fonte:

Speroff L, Rowan J, Symons J, Genant H, Wilborn W. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study) (a randomized controlled study). JAMA. 1996;276:1397–1403. 
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al.
 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women (Heart and Estrogen/progestin Replacement Study (HERS) Research Group). 
JAMA. 1998;280:605–613.
Komulainen MH, Kroger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, et al.
 HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: a 5 year randomized trial. 
Maturitas. 1998;31:45–54. 
Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial
. 
JAMA. 2002;288:321–333.
The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291:1701–1712. 
MacLennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;4:CD002978.
Cardozo L, Bachmann G, McLish D, Fonda D, Birgerson L. Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee. Obstet Gynecol. 1998;92:722–727.
LeBlanc ES, Janowsky J, Chan BKS, Nelson HD. Hormone replacement therapy and cognition: systematic review and meta-analysis. JAMA. 2001;285:1489–1499.
Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women (the Women's Health Initiative Memory study: a randomized controlled trial). JAMA. 2003;289:2651–2662.

 

 

#Leia o Consenso da Associação Brasileira do Climatério

atualizado e revisado em 24 out 2009

Esta página é oferecida por

A maior página de Saúde Feminina no Brasil